News | February 24, 2012

Emergency Department Admissions Down for Heart Attack, Up for Stroke

David Seaberg, M.D., CPE, FACEP, president of the American College of Emergency Physicians (ACEP)


February 24, 2012 — A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for heart attack decreased slightly (1.7 percent) for Medicare patients, but admissions for stroke increased by 2.2 percent. Heart attack and stroke were among the conditions with the highest mortality rates, with nearly one in 10 heart attack patients dying, and nearly one in 10 stroke patients (9.24 percent) dying, after admission to the hospital.

David Seaberg, M.D., CPE, FACEP, president of the American College of Emergency Physicians (ACEP), said the information is useful for tracking mortality rates for heart attack and stroke patients who are admitted to the hospital, although the report itself is a measure of inpatient hospital care, not emergency care.

"The information about heart attack and stroke admissions is not surprising," said Seaberg. "Emergency physicians encourage all adults, especially seniors, to know the warning signs of stroke and heart attack. It's important to err on the side of caution, call 911 and get to the nearest emergency department as soon as possible if you think you're having a stroke or heart attack."

According to the report, nearly 61 percent of hospital admissions among seniors begin in the emergency department, more than any other age group.

The new data are being released in HealthGrades "2012 Emergency Medicine in American Hospitals" report, in which they rank the nation's top hospitals.

Seaberg added that the emergency department is the safety net of the entire health care system and the first stop for millions entering a hospital each year in search of care.

For more information: www.acep.org


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now